Tangye SG, Al-Herz W, Bousfiha A, et al. Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2022;42(7):1473-1507.
[2]
Fischer A, Le Deist F, Hacein-Bey-Abina S, et al. Severe combined immunodeficiency. A model for gene therapy for primary immunodeficiencies. Ann N Y Acad Sci. 2003;996:133-138.
[3]
Buckley RH. Molecular defects in human severe combined immunodeficiency and approaches to therapy. FEBS Lett. 2003;539(1-3):57-63.
[4]
Pai SY, Logan BR, Griffith LM, et al. Transplantation outcomes for severe combined immunodeficiency, 2000-2009. N Engl J Med. 2014;371(5):434-446.
[5]
Kwan A, Abraham RS, Currier R, et al. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA. 2014;312(7):729-738.
[6]
Cunningham-Rundles C, Sidi P, Estrella L, Meydan N. Identifying primary immunodeficiency in clinical practice. Am J Clin Dermatol. 2019;20(5):617-631.
[7]
Chinn IK, Shearer WT. Severe combined immunodeficiency in infants. Clin Rev Allergy Immunol. 2019;56(1):54-65.
[8]
Dvorak CC, Cowan MJ, Logan BR, et al. The natural history of children with severe combined immunodeficiency: baseline data from the SCID newborn screening program. J Pediatr. 2013;162(6):1180-1185.
[9]
Haddad E, Hoenig M. Hematopoietic stem cell transplantation for severe combined immunodeficiency. Annu Rev Med. 2019;70:201-213.
[10]
Notarangelo LD, Bacchetta R, Castagnoli S, et al. Wiskott-Aldrich syndrome: a comprehensive review. Ann N Y Acad Sci. 2018;1415(1):1-17.